Drugs / cotrimoxazole-trimethoprim
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02375295 | Mar 2015 → Dec 2023 | urolithiasis | University of British Columbia | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cotrimoxazole-trimethoprim | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02375295 ↗ |
| Route | Oral | “Oral antibiotics: ciprofloxacin, cotrimoxazole-trimethoprim, or macrodantin are administered” NCT02375295 ↗ |